SE7414855L - - Google Patents

Info

Publication number
SE7414855L
SE7414855L SE7414855A SE7414855A SE7414855L SE 7414855 L SE7414855 L SE 7414855L SE 7414855 A SE7414855 A SE 7414855A SE 7414855 A SE7414855 A SE 7414855A SE 7414855 L SE7414855 L SE 7414855L
Authority
SE
Sweden
Application number
SE7414855A
Other versions
SE404376B (sv
Inventor
W D Celmer
F C Sciavolino
I B Routien
W P Cullen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7414855L publication Critical patent/SE7414855L/xx
Publication of SE404376B publication Critical patent/SE404376B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07GCOMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G11/00Antibiotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/863Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
SE7414855A 1974-01-09 1974-11-26 Framstellning av en blandning av 3-tiometulrifamycin s, 3-tiometylrifamycin sv, rifamycin s, rifamycin sv och en ny ansamycin betecknad 32 656 genom odling av en mikroorganism benemnd micromonospora lacustris sp nov ... SE404376B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US431845A US3914218A (en) 1974-01-09 1974-01-09 3-Methylthiorifamycins

Publications (2)

Publication Number Publication Date
SE7414855L true SE7414855L (da) 1975-07-10
SE404376B SE404376B (sv) 1978-10-02

Family

ID=23713694

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7414855A SE404376B (sv) 1974-01-09 1974-11-26 Framstellning av en blandning av 3-tiometulrifamycin s, 3-tiometylrifamycin sv, rifamycin s, rifamycin sv och en ny ansamycin betecknad 32 656 genom odling av en mikroorganism benemnd micromonospora lacustris sp nov ...

Country Status (24)

Country Link
US (1) US3914218A (da)
JP (1) JPS5748198B2 (da)
AR (1) AR207344A1 (da)
AT (1) AT338970B (da)
BE (1) BE824104A (da)
CA (1) CA1033674A (da)
CH (1) CH596311A5 (da)
CS (1) CS191924B2 (da)
DD (1) DD115917A5 (da)
DE (1) DE2500898A1 (da)
DK (1) DK137841B (da)
ES (1) ES433631A1 (da)
FI (1) FI53983C (da)
FR (1) FR2256756B1 (da)
GB (1) GB1478469A (da)
HU (1) HU173914B (da)
IE (1) IE40205B1 (da)
IL (1) IL46268A (da)
LU (1) LU71608A1 (da)
NL (1) NL7500200A (da)
PL (1) PL94189B1 (da)
RO (1) RO63768A (da)
SE (1) SE404376B (da)
SU (1) SU575038A3 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
JPS5653682A (en) * 1979-10-09 1981-05-13 Kanebo Ltd Production of novel rifamycin derivative
US4877735A (en) * 1987-06-19 1989-10-31 Takeda Chemical Industries, Ltd. Process for producing 2-keto-L-gulonic acid
USD874704S1 (en) 2016-07-26 2020-02-04 Solar Eco Systems Solar light
USD870945S1 (en) 2016-07-26 2019-12-24 Solar Eco Systems Solar light
CN116768910B (zh) * 2023-08-18 2023-10-31 山东齐都药业有限公司 一种利福布汀的精制方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1165179A (en) * 1966-10-25 1969-09-24 Lepetit Spa Derivatives of Rifamycin SV

Also Published As

Publication number Publication date
FI53983B (fi) 1978-05-31
IE40205L (en) 1975-07-09
FI53983C (fi) 1978-09-11
GB1478469A (en) 1977-06-29
FI750038A (da) 1975-07-10
DK673174A (da) 1975-09-01
IE40205B1 (en) 1979-04-11
AU7681374A (en) 1976-06-24
CA1033674A (en) 1978-06-27
NL7500200A (nl) 1975-07-11
AR207344A1 (es) 1976-09-30
FR2256756B1 (da) 1978-06-30
CH596311A5 (da) 1978-03-15
ES433631A1 (es) 1977-02-16
RO63768A (fr) 1978-12-15
DK137841B (da) 1978-05-16
IL46268A (en) 1977-06-30
LU71608A1 (da) 1975-12-09
ATA9575A (de) 1977-01-15
CS191924B2 (en) 1979-07-31
JPS50100293A (da) 1975-08-08
IL46268A0 (en) 1975-05-22
SU575038A3 (ru) 1977-09-30
AT338970B (de) 1977-09-26
HU173914B (hu) 1979-09-28
DE2500898A1 (de) 1975-07-17
SE404376B (sv) 1978-10-02
US3914218A (en) 1975-10-21
DD115917A5 (da) 1975-10-20
FR2256756A1 (da) 1975-08-01
BE824104A (fr) 1975-07-07
PL94189B1 (da) 1977-07-30
JPS5748198B2 (da) 1982-10-14
DK137841C (da) 1978-10-16

Similar Documents

Publication Publication Date Title
FR2260209A1 (da)
JPS50136379A (da)
FR2266705A1 (da)
FR2256756B1 (da)
FR2288113B1 (da)
FR2283599B1 (da)
AU7459374A (da)
JPS50141227A (da)
FR2268859B1 (da)
JPS50103311U (da)
JPS50102385A (da)
FR2278421B3 (da)
JPS50120976U (da)
JPS50141312A (da)
JPS50115263U (da)
JPS50120287U (da)
JPS50125793U (da)
JPS50127227A (da)
JPS50105031U (da)
JPS50127805U (da)
CH573816A5 (da)
CH572117A5 (da)
BE833391A (da)
CH586863A5 (da)
CH573827A5 (da)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7414855-2

Effective date: 19891114

Format of ref document f/p: F